Amarantus Bioscience Holdings Inc (AMBS)

[myarmalite]

Amarantus pays 9% of proceeds to Memory DX. That means for every 1million Memory DX generates, memory DX income from that would be 90k. Amarantus keeps 910,000 bucks! Running a company myself I can tell you anything under 30% is steal AMBS negotiated 9%! 40,000 in cash will be covered by MJFF. This is a smoking deal for amarantus! This adventure will cost AMBS nothing other than shares.

RBCC and AMBS with the JV made the Miami herald this last wednesday, link: http://www.miamiherald.com/2012/12/19/3148606/rbccs-pending-jv-partner-amarantus.html

This news was out Dec 14 it was just waiting to be drafted.
Amarantus BioScience, Inc. (AMBS) Licenses Memory Dx LymPro Alzheimer’s Diagnostic Test
http://ewallstreeter.com/amarantus-bioscience-inc-ambs-licenses-memory-dx-lympro-alzheimer-s-diagnostic-test-8234/#

This article goes further in depth... You guys should bookmark these two sites if your going to be playing in the bio's.
http://www.ivdtechnology.com/blog/ivdt-insight/amarantus-bioscience-licenses-alzheimers-diagnostic-memory-dx

Pipeline agreement between Memory DX and AMBS:
http://www.biocentury.com/companies/memory_dx_llc

Now it's neat to look at the trademark!

http://trademarks.justia.com/856/62/memory-dx-85662008.html